Table 4.
The association of hypertension, diabetes mellitus, metabolic syndrome, and cardiovascular disease with FLI
| FLI <20 (n=5,565) | FLI 20–59 (n=3,408) | 95% CI | FLI ≥60 (n=1,134) | 95% CI | Nagelkerke R2 | |
|---|---|---|---|---|---|---|
| Hypertension | ||||||
| Model 1 | 1.00 | 2.49 | 2.19–2.84 | 5.57 | 4.56–6.80 | 0.365 |
| Model 2 | 1.00 | 2.62 | 2.29–2.99 | 6.27 | 5.05–7.77 | 0.367 |
| Model 3 | 1.00 | 1.76 | 1.48–2.10 | 2.92 | 2.18–3.90 | 0.380 |
| Diabetes mellitus | ||||||
| Model 1 | 1.00 | 2.27 | 1.83–2.81 | 5.49 | 4.19–7.19 | 0.202 |
| Model 2 | 1.00 | 2.26 | 1.82–2.82 | 5.25 | 3.96–6.96 | 0.211 |
| Model 3 | 1.00 | 2.09 | 1.60–2.71 | 4.38 | 2.96–6.49 | 0.218 |
| Metabolic syndrome | ||||||
| Model 1 | 1.00 | 10.90 | 9.36–12.69 | 83.25 | 63.39–109.33 | 0.528 |
| Model 2 | 1.00 | 8.82 | 7.47–10.41 | 62.20 | 47.09–82.19 | 0.569 |
| Model 3 | 1.00 | 5.52 | 4.39–6.95 | 24.85 | 17.33–35.64 | 0.643 |
| Cardiovascular disease | ||||||
| Model 1 | 1.00 | 1.9 | 1.45–2.50 | 1.90 | 1.32–2.64 | 0.183 |
| Model 2 | 1.00 | 1.85 | 1.39–2.47 | 1.42 | 0.96–2.12 | 0.202 |
| Model 3 | 1.00 | 1.28 | 0.91–1.82 | 0.72 | 0.40–1.29 | 0.211 |
Notes: Model 1: adjusted for age and sex. Model 2: adjusted for age, sex, HDL-cholesterol, and LDL-cholesterol. Model 3: adjusted for age, sex, HDL-cholesterol, LDL-cholesterol, fasting glucose, body mass index, smoking status with hypertension. Adjusted for age, sex, HDL-cholesterol, LDL-cholesterol, SBP and DBP, body mass index, smoking status with diabetes mellitus. Adjusted for age, sex, HDL-cholesterol, LDL-cholesterol, fasting glucose, SBP and DBP, body mass index, smoking status with metabolic syndrome and cardiovascular disease.
Abbreviations: FLI, fatty liver index; LDL, low-density lipoprotein; HDL, high-density lipoprotein.